Poly Medicure Ltd has acquired Wellinq, a Netherlands-based innovative medical device company, for an undisclosed amount. This corporate acquisition sees Poly Medicure Ltd gaining Wellinq's specialized expertise in developing and delivering advanced minimal invasive vascular solutions. Wellinq has over 25 years of experience in catheter-based technologies, providing improved and new solutions to interventional vascular markets, with a focus on coronary and peripheral applications. Its offerings include state-of-the-art guiding and angiographic catheters, semi-finished products, and contract development and manufacturing services for catheters and sensor integration.
Wellinq operates multiple manufacturing locations in the Netherlands and holds significant international certifications, including ISO 13485, CE 13485, and FDA approvals for its products, which are marketed under its own PendraCare brand, as OEM solutions, and as components. The strategic acquisition by Poly Medicure Ltd is expected to significantly expand its footprint in the high-growth interventional vascular sector. By integrating Wellinq's established product portfolio and in-house capabilities for large-scale production of catheters and advanced sensor design, Poly Medicure Ltd enhances its technological prowess and market reach in critical medical device areas.
The combination of Poly Medicure Ltd and Wellinq is anticipated to create substantial synergies. Wellinq’s commitment to rapid and reliable development of new products for vascular diagnostics diseases, coupled with its advanced manufacturing processes, will complement Poly Medicure Ltd’s existing operations. This acquisition aims to accelerate innovation, optimize production efficiencies, and broaden the combined entity’s global access to healthcare markets. The integration is expected to empower both companies to deliver a more comprehensive suite of patient-centric solutions and empower healthcare professionals worldwide.